Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EBIT Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 229.27-86.50-2.11181.6027.46

What is the latest EBIT Growth ratio of SAMRAT PHARMACHEM ?

The latest EBIT Growth ratio of SAMRAT PHARMACHEM is 229.27 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025229.27
Mar2024-86.50
Mar2023-2.11
Mar2022181.60
Mar202127.46

How is EBIT Growth of SAMRAT PHARMACHEM Trending?

Years EBIT Growth % Change
Mar2025 229.27
Positive
Mar2024 -86.5
Negative
Mar2023 -2.11
Negative
Mar2022 181.6
561.33
Mar2021 27.46 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EBIT Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹64.0 Cr 5.9% 1.9% -32.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

5.9%

1.9%

-32.8%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses